According to Bedford, Fluconazole injection is an antifungal agent indicated for oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and is also indicated for the prophylaxis of candidiasis. This product is AP rated and is equivalent to Diflucan by Pfizer.
In addition to the glass vial presentations, Bedford Laboratories will supply fluconazole injection as a sterile iso-osmotic solution containing 2mg/ml of fluconazole in 0.9% sodium chloride diluent in the following presentations: 200mg/100ml in single-dose PVC flexible containers packaged in cartons containing 10 bags and 400mg/200ml in single-dose PVC flexible containers packaged in cartons containing 10 bags.
David Gaugh, vice president of Bedford Laboratories, said: “In our continuing effort to offer the most comprehensive and cost effective line of injectables in the multisource industry, Bedford Laboratories is pleased to begin offering this product in PVC flexible containers. This product represents Bedford’s entry into the intravenous bag market and demonstrates our ongoing commitment to providing a broad based portfolio of products.”